Henry W. Pauls

1.9k total citations
44 papers, 943 citations indexed

About

Henry W. Pauls is a scholar working on Organic Chemistry, Molecular Biology and Hematology. According to data from OpenAlex, Henry W. Pauls has authored 44 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 16 papers in Molecular Biology and 15 papers in Hematology. Recurrent topics in Henry W. Pauls's work include Blood Coagulation and Thrombosis Mechanisms (14 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Chemical Synthesis and Analysis (7 papers). Henry W. Pauls is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (14 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Chemical Synthesis and Analysis (7 papers). Henry W. Pauls collaborates with scholars based in United States, Canada and France. Henry W. Pauls's co-authors include William R. Ewing, Bert Fraser‐Reid, Alfred P. Spada, Yong Mi Choi-Sledeski, Michael R. Becker, S. Maignan, J.P. Guilloteau, Vincent Mikol, Scott I. Klein and Karen Brown and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Henry W. Pauls

43 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry W. Pauls United States 17 390 368 215 127 122 44 943
Joanne M. Smallheer United States 16 301 0.8× 357 1.0× 150 0.7× 43 0.3× 67 0.5× 35 859
J.P. Guilloteau France 13 652 1.7× 156 0.4× 100 0.5× 109 0.9× 40 0.3× 17 1.0k
Tomas Fex Sweden 15 462 1.2× 271 0.7× 43 0.2× 62 0.5× 10 0.1× 32 817
Garima Gupta India 24 427 1.1× 561 1.5× 88 0.4× 33 0.3× 24 0.2× 46 1.2k
Claire A. Minshull United Kingdom 12 488 1.3× 340 0.9× 63 0.3× 116 0.9× 12 0.1× 12 961
Julie A. Krueger United States 18 394 1.0× 237 0.6× 140 0.7× 52 0.4× 75 0.6× 31 906
Kyle Elrod United States 14 269 0.7× 110 0.3× 145 0.7× 63 0.5× 18 0.1× 23 606
Roderick J. Sorenson United States 19 647 1.7× 632 1.7× 150 0.7× 46 0.4× 16 0.1× 35 1.4k
Daniel R. McMasters United States 22 562 1.4× 373 1.0× 62 0.3× 181 1.4× 50 0.4× 40 1.2k
Harold R. Almond United States 18 590 1.5× 472 1.3× 49 0.2× 257 2.0× 38 0.3× 32 1.2k

Countries citing papers authored by Henry W. Pauls

Since Specialization
Citations

This map shows the geographic impact of Henry W. Pauls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry W. Pauls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry W. Pauls more than expected).

Fields of papers citing papers by Henry W. Pauls

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry W. Pauls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry W. Pauls. The network helps show where Henry W. Pauls may publish in the future.

Co-authorship network of co-authors of Henry W. Pauls

This figure shows the co-authorship network connecting the top 25 collaborators of Henry W. Pauls. A scholar is included among the top collaborators of Henry W. Pauls based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry W. Pauls. Henry W. Pauls is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaplan, Nachum, Monique Albert, Donald E. Awrey, et al.. (2012). Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor. Antimicrobial Agents and Chemotherapy. 56(11). 5865–5874. 92 indexed citations
2.
Liang, Guyan, Suzanne C. Aldous, Julian Levell, et al.. (2011). Structure-based library design and the discovery of a potent and selective mast cell β-tryptase inhibitor as an oral therapeutic agent. Bioorganic & Medicinal Chemistry Letters. 22(2). 1049–1054. 16 indexed citations
3.
Sampson, Peter B., Christine J. Picard, Andrew Leeson, et al.. (2009). Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI). Bioorganic & Medicinal Chemistry Letters. 19(18). 5355–5358. 17 indexed citations
4.
Hopkins, Corey R., Steven S. Kaye, Henry W. Pauls, et al.. (2005). Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase. Bioorganic & Medicinal Chemistry Letters. 15(11). 2734–2737. 29 indexed citations
5.
Guertin, Kevin R., Scott I. Klein, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity. Bioorganic & Medicinal Chemistry Letters. 12(12). 1671–1674. 45 indexed citations
6.
Klein, Scott I., Kevin R. Guertin, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 1: P4 and side-Chain modifications for improved In vitro potency. Bioorganic & Medicinal Chemistry Letters. 12(12). 1667–1670. 14 indexed citations
7.
Pauls, Henry W. & William R. Ewing. (2001). The Design of Competitive, Small-molecule Inhibitors of Coagulation Factor Xa. Current Topics in Medicinal Chemistry. 1(2). 83–100. 27 indexed citations
8.
Gong, Yong, Henry W. Pauls, Alfred P. Spada, et al.. (2000). Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa. Bioorganic & Medicinal Chemistry Letters. 10(3). 217–221. 9 indexed citations
9.
Gong, Yong, Michael R. Becker, Yong Mi Choi-Sledeski, et al.. (2000). Solid-phase parallel synthesis of azarene pyrrolidinones as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(10). 1033–1036. 13 indexed citations
10.
Gong, Yong & Henry W. Pauls. (2000). ChemInform Abstract: A Convenient Synthesis of Heteroaryl Benzoic Acids via Suzuki Reaction.. ChemInform. 31(41). 1 indexed citations
11.
Chu, Valeria, Karen Brown, Dennis Colussi, et al.. (2000). In Vitro Characterization of a Novel Factor Xa Inhibitor, RPR 130737. Thrombosis Research. 99(1). 71–82. 16 indexed citations
12.
Becker, Michael R., William R. Ewing, Henry W. Pauls, et al.. (1999). Synthesis, SAR and in vivo activity of novel thienopyridine sulfonamide pyrrolidinones as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(18). 2753–2758. 19 indexed citations
13.
Regan, John R., Daniel McGarry, Joseph G. Bruno, et al.. (1997). Anionic- and Lipophilic-Mediated Surface Binding Inhibitors of Human Leukocyte Elastase. Journal of Medicinal Chemistry. 40(21). 3408–3422. 12 indexed citations
14.
Jarvis, Michael F., et al.. (1993). Characterization of the bisphosphonate recognition site on hydroxyapatite using radioligand binding techniques with [14C]citric acid. Calcified Tissue International. 52(5). 372–377. 10 indexed citations
15.
Pliura, Diana H., et al.. (1992). Irreversible Inhibition of Transglutaminases by Sulfonium Methylketones: Optimization of Specificity and Potency with w-Aminoacyl Spacers. Journal of enzyme inhibition. 6(3). 181–194. 13 indexed citations
16.
Robinson, Valerie J., Henry W. Pauls, Peter J. Coles, Roger A. Smith, & Allen Krantz. (1992). Carbon-13 NMR characterization of the papain adduct formed by peptidyl acyloxy-, aryloxy-, and chloromethyl ketone irreversible inhibitors. Bioorganic Chemistry. 20(1). 42–54. 10 indexed citations
17.
Smith, Roger A., Leslie J. Copp, Peter J. Coles, et al.. (1988). New inhibitors of cysteine proteinases. Peptidyl acyloxymethyl ketones and the quiescent nucleofuge strategy. Journal of the American Chemical Society. 110(13). 4429–4431. 53 indexed citations
18.
Pauls, Henry W. & Bert Fraser‐Reid. (1984). Stereocontrolled routes to cis-hydroxyamino sugars. Part VI. A synthesis of garosamine. Canadian Journal of Chemistry. 62(8). 1532–1538. 10 indexed citations
19.
Pauls, Henry W. & Bert Fraser‐Reid. (1980). A novel synthesis of methyl .alpha.-L-garosaminide which illustrates a stereocontrolled approach to the cis-hydroxyamino moiety of amino sugars. Journal of the American Chemical Society. 102(11). 3956–3957. 28 indexed citations
20.
Pauls, Henry W., et al.. (1952). The effect of pitressin infusion on blood pressure of the rabbit, cat, and rat. American Heart Journal. 44(1). 131–142. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026